GlassScriptPhysician profile
Jonathan L Altomar
NPI 1306005905
$11,007.10
in general payments reported to CMS, 2019-2025
6 companies · $7,405 in 2025
The $7,405 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $121 · 2022: $134 · 2023: $59.73 · 2024: $3,162 · 2025: $7,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,043 · Travel and Lodging: $3,074 · Food and Beverage: $2,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,042.86 |
| Travel and Lodging | $3,073.65 |
| Food and Beverage | $2,510.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,504.32 | 2024-2025 | |
| Smith+Nephew, INC. | $1,980.58 | 2022-2025 | Grafix Pl, Oasis Micro, Stravix Mesh |
| Kci USA, INC. | $363.10 | 2019-2022 | |
| Tela Bio, INC. | $90.01 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $38.27 | 2024 | Echelon Flex |
| Abbvie INC. | $30.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Altomar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.